Bionano Genomics, Inc. — Director's Dealing 2022

Aug 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc. (BNGO)
CIK: 0001411690
Period of Report: 2022-08-15

Reporting Person: Linney Yvonne (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-15	Common Stock	M	20000	$0.38	Acquired	20000	Direct
2022-08-15	Common Stock	S	20000	$3.6201	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-15	Stock Option (Right to Buy)	$0.38	M	20000	Disposed	2030-05-04	Common Stock (20000.0)	Direct

Footnotes

F1: The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).